139 related articles for article (PubMed ID: 9224814)
1. Structural basis for differential induction of spermidine/spermine N1-acetyltransferase activity by novel spermine analogs.
Fogel-Petrovic M; Kramer DL; Vujcic S; Miller J; McManis JS; Bergeron RJ; Porter CW
Mol Pharmacol; 1997 Jul; 52(1):69-74. PubMed ID: 9224814
[TBL] [Abstract][Full Text] [Related]
2. Effects of polyamines, polyamine analogs, and inhibitors of protein synthesis on spermidine-spermine N1-acetyltransferase gene expression.
Fogel-Petrovic M; Vujcic S; Brown PJ; Haddox MK; Porter CW
Biochemistry; 1996 Nov; 35(45):14436-44. PubMed ID: 8916930
[TBL] [Abstract][Full Text] [Related]
3. Sequence specific antisense oligonucleotide analog interference with spermidine/spermine N1-acetyltransferase gene expression.
Fogel-Petrovic M; Vujcic S; Häner R; Regenass U; Mett H; Porter CW
Anticancer Res; 1996; 16(5A):2517-23. PubMed ID: 8917345
[TBL] [Abstract][Full Text] [Related]
4. Polyamine catabolism in platinum drug action: Interactions between oxaliplatin and the polyamine analogue N1,N11-diethylnorspermine at the level of spermidine/spermine N1-acetyltransferase.
Hector S; Porter CW; Kramer DL; Clark K; Prey J; Kisiel N; Diegelman P; Chen Y; Pendyala L
Mol Cancer Ther; 2004 Jul; 3(7):813-22. PubMed ID: 15252142
[TBL] [Abstract][Full Text] [Related]
5. Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines.
Porter CW; Ganis B; Libby PR; Bergeron RJ
Cancer Res; 1991 Jul; 51(14):3715-20. PubMed ID: 2065327
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Porter CW; Bernacki RJ; Miller J; Bergeron RJ
Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice with activated polyamine catabolism due to overexpression of spermidine/spermine N1-acetyltransferase show enhanced sensitivity to the polyamine analog, N1, N11-diethylnorspermine.
Alhonen L; Pietilä M; Halmekytö M; Kramer DL; Jänne J; Porter CW
Mol Pharmacol; 1999 Apr; 55(4):693-8. PubMed ID: 10101027
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.
Bernacki RJ; Bergeron RJ; Porter CW
Cancer Res; 1992 May; 52(9):2424-30. PubMed ID: 1568212
[TBL] [Abstract][Full Text] [Related]
9. Polyamine and polyamine analog regulation of spermidine/spermine N1-acetyltransferase in MALME-3M human melanoma cells.
Fogel-Petrovic M; Shappell NW; Bergeron RJ; Porter CW
J Biol Chem; 1993 Sep; 268(25):19118-25. PubMed ID: 8360194
[TBL] [Abstract][Full Text] [Related]
10. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells.
Kramer DL; Fogel-Petrovic M; Diegelman P; Cooley JM; Bernacki RJ; McManis JS; Bergeron RJ; Porter CW
Cancer Res; 1997 Dec; 57(24):5521-7. PubMed ID: 9407962
[TBL] [Abstract][Full Text] [Related]
11. Small interfering RNA suppression of polyamine analog-induced spermidine/spermine n1-acetyltransferase.
Chen Y; Kramer DL; Jell J; Vujcic S; Porter CW
Mol Pharmacol; 2003 Nov; 64(5):1153-9. PubMed ID: 14573765
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes.
Shappell NW; Miller JT; Bergeron RJ; Porter CW
Anticancer Res; 1992; 12(4):1083-9. PubMed ID: 1503400
[TBL] [Abstract][Full Text] [Related]
13. Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine.
Gabrielson E; Tully E; Hacker A; Pegg AE; Davidson NE; Casero RA
Cancer Chemother Pharmacol; 2004 Aug; 54(2):122-6. PubMed ID: 15138709
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of spermidine/spermine N1-acetyltransferase activity in cisplatin-sensitive and -resistant ovarian cancer cells in response to N1,N12-bis(ethyl)spermine involves transcriptional and post-transcriptional regulation.
Marverti G; Bettuzzi S; Astancolle S; Pinna C; Monti MG; Moruzzi MS
Eur J Cancer; 2001 Jan; 37(2):281-9. PubMed ID: 11166157
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human spermidine/spermine N1-acetyltransferase purified from cultured melanoma cells.
Libby PR; Ganis B; Bergeron RJ; Porter CW
Arch Biochem Biophys; 1991 Feb; 284(2):238-44. PubMed ID: 1989509
[TBL] [Abstract][Full Text] [Related]
16. Differential post-transcriptional control of ornithine decarboxylase and spermidine-spermine N1-acetyltransferase by polyamines.
Fogel-Petrovic M; Vujcic S; Miller J; Porter CW
FEBS Lett; 1996 Aug; 391(1-2):89-94. PubMed ID: 8706937
[TBL] [Abstract][Full Text] [Related]
17. Stress induction of the spermidine/spermine N1-acetyltransferase by a post-transcriptional mechanism in mammalian cells.
Gerner EW; Kurtts TA; Fuller DJ; Casero RA
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):491-5. PubMed ID: 8396915
[TBL] [Abstract][Full Text] [Related]
18. Two active copies of the X-linked gene spermidine/spermine N1-acetyltransferase (SSAT) in a female lung cancer cell line are associated with an increase in sensitivity to an antitumor polyamine analogue.
Mank-Seymour AR; Murray TR; Berkey KA; Xiao L; Kern S; Casero RA
Clin Cancer Res; 1998 Aug; 4(8):2003-8. PubMed ID: 9717831
[TBL] [Abstract][Full Text] [Related]
19. Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells.
Libby PR; Henderson M; Bergeron RJ; Porter CW
Cancer Res; 1989 Nov; 49(22):6226-31. PubMed ID: 2804970
[TBL] [Abstract][Full Text] [Related]
20. Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.
Tummala R; Diegelman P; Hector S; Kramer DL; Clark K; Zagst P; Fetterly G; Porter CW; Pendyala L
Cancer Chemother Pharmacol; 2011 Feb; 67(2):401-14. PubMed ID: 20443003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
